Bejarano D, Peng K, Laketa V, Börner K, Jost K, Lucic B, et al. HIV-1 nuclear import in macrophages is regulated by CPSF6-capsid interactions at the nuclear pore complex. elife. 2019;8: pubmed publisher

Sierra Madero J, Ellenberg S, Rassool M, Tierney A, Belaunzarán Zamudio P, López Martínez A, et al. Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial. Lancet HIV. 2014;1:e60-7 pubmed publisher

Østerud B, Unruh D, Olsen J, Kirchhofer D, Owens A, Bogdanov V. Procoagulant and proinflammatory effects of red blood cells on lipopolysaccharide-stimulated monocytes. J Thromb Haemost. 2015;13:1676-82 pubmed publisher

Yoshinaga T, Kobayashi M, Seki T, Miki S, Wakasa Morimoto C, Suyama Kagitani A, et al. Antiviral characteristics of GSK1265744, an HIV integrase inhibitor dosed orally or by long-acting injection. Antimicrob Agents Chemother. 2015;59:397-406 pubmed publisher

Gouwy M, De Buck M, Pörtner N, Opdenakker G, Proost P, Struyf S, et al. Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines. Eur J Immunol. 2015;45:101-12 pubmed publisher

Pérez Martínez L, Perez Matute P, Aguilera Lizarraga J, Rubio Mediavilla S, Narro J, Recio E, et al. Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD). J Antimicrob Chemother. 2014;69:1903-10 pubmed publisher